Frequency and genotypic distribution of GB virus C (GBV-C) among Colombian population with Hepatitis B (HBV) or Hepatitis C (HCV) infection

Imagem de Miniatura
Arquivos
art_ALVARADO-MORA_Frequency_and_genotypic_distribution_of_GB_virus_C_2011.PDF (853.24 KB)
Citações na Scopus
17
Tipo de produção
article
Data de publicação
2011
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Autores
BOTELHO, Livia
NISHIYA, Anna
GUTIERREZ, Maria F.
Citação
VIROLOGY JOURNAL, v.8, article ID 345, 7p, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: GB virus C (GBV-C) is an enveloped positive-sense ssRNA virus belonging to the Flaviviridae family. Studies on the genetic variability of the GBV-C reveals the existence of six genotypes: genotype 1 predominates in West Africa, genotype 2 in Europe and America, genotype 3 in Asia, genotype 4 in Southwest Asia, genotype 5 in South Africa and genotype 6 in Indonesia. The aim of this study was to determine the frequency and genotypic distribution of GBV-C in the Colombian population. Methods: Two groups were analyzed: i) 408 Colombian blood donors infected with HCV (n = 250) and HBV (n = 158) from Bogota and ii) 99 indigenous people with HBV infection from Leticia, Amazonas. A fragment of 344 bp from the 5' untranslated region (5' UTR) was amplified by nested RT PCR. Viral sequences were genotyped by phylogenetic analysis using reference sequences from each genotype obtained from GenBank (n = 160). Bayesian phylogenetic analyses were conducted using Markov chain Monte Carlo (MCMC) approach to obtain the MCC tree using BEAST v. 1.5.3. Results: Among blood donors, from 158 HBsAg positive samples, eight 5.06% (n = 8) were positive for GBV-C and from 250 anti-HCV positive samples, 3.2%(n = 8) were positive for GBV-C. Also, 7.7% (n = 7) GBV-C positive samples were found among indigenous people from Leticia. A phylogenetic analysis revealed the presence of the following GBV-C genotypes among blood donors: 2a (41.6%), 1 (33.3%), 3 (16.6%) and 2b (8.3%). All genotype 1 sequences were found in co-infection with HBV and 4/5 sequences genotype 2a were found in co-infection with HCV. All sequences from indigenous people from Leticia were classified as genotype 3. The presence of GBV-C infection was not correlated with the sex (p = 0.43), age (p = 0.38) or origin (p = 0.17). Conclusions: It was found a high frequency of GBV-C genotype 1 and 2 in blood donors. The presence of genotype 3 in indigenous population was previously reported from Santa Marta region in Colombia and in native people from Venezuela and Bolivia. This fact may be correlated to the ancient movements of Asian people to South America a long time ago.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/23481
Referências
  1. Mora MVA, 2011, INFECT GENET EVOL, V11, P103, DOI 10.1016/j.meegid.2010.10.003
  2. Barusruk Sahapat, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P289
  3. Casteling A, 1998, J MED VIROL, V55, P103, DOI 10.1002/(SICI)1096-9071(199806)55:2<103::AID-JMV4>3.0.CO;2-6
  4. Tucker TJ, 1999, J MED VIROL, V59, P52, DOI 10.1002/(SICI)1096-9071(199909)59:1<52::AID-JMV9>3.0.CO;2-D
  5. Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
  6. Linnen J, 1996, SCIENCE, V271, P505, DOI 10.1126/science.271.5248.505
  7. Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
  8. Loureiro CL, 2002, J MED VIROL, V68, P357, DOI 10.1002/jmv.10211
  9. Moaven LD, 1996, MED J AUSTRALIA, V165, P369
  10. Seifried C, 2004, TRANSFUSION, V44, P268, DOI 10.1111/j.1537-2995.2004.00665.x
  11. Laskus T, 1997, J VIROL, V71, P7804
  12. Tillmann HL, 2001, ANTIVIR RES, V52, P83, DOI 10.1016/S0166-3542(01)00172-3
  13. Dawson GJ, 1996, J MED VIROL, V50, P97, DOI 10.1002/(SICI)1096-9071(199609)50:1<97::AID-JMV16>3.0.CO;2-V
  14. Stapleton JT, 2011, J GEN VIROL, V92, P233, DOI 10.1099/vir.0.027490-0
  15. SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564
  16. Konomi N, 1999, J CLIN MICROBIOL, V37, P3291
  17. Smith DB, 1997, J GEN VIROL, V78, P1533
  18. Bjorkman P, 2001, VOX SANG, V81, P148, DOI 10.1046/j.1423-0410.2001.00098.x
  19. Muerhoff AS, 2006, J MED VIROL, V78, P105, DOI 10.1002/jmv.20510
  20. Tanaka E, 1996, ANN INTERN MED, V125, P740
  21. Jarvis LM, 1996, LANCET, V348, P1352, DOI 10.1016/S0140-6736(96)04041-X
  22. Naito H, 1999, J CLIN MICROBIOL, V37, P1217
  23. Suzuki Y, 1999, J MOL EVOL, V48, P383, DOI 10.1007/PL00006482
  24. GonzalezPerez MA, 1997, J MED VIROL, V52, P149, DOI 10.1002/(SICI)1096-9071(199706)52:2<149::AID-JMV5>3.0.CO;2-3
  25. Muerhoff AS, 1996, J HEPATOL, V25, P379, DOI 10.1016/S0168-8278(96)80125-5
  26. Alter HJ, 1997, TRANSFUSION, V37, P569, DOI 10.1046/j.1537-2995.1997.37697335149.x
  27. Leary TP, 1996, J MED VIROL, V48, P60, DOI 10.1002/(SICI)1096-9071(199601)48:1<60::AID-JMV10>3.0.CO;2-A
  28. Berzsenyi MD, 2005, J CLIN VIROL, V33, P257, DOI 10.1016/j.jcv.2005.04.002
  29. Bouchardeau F, 2000, TRANSFUSION, V40, P875, DOI 10.1046/j.1537-2995.2000.40070875.x
  30. CAVALLISFORZA LL, 1991, SCI AM, V265, P72
  31. Cesaire R, 1999, J MED VIROL, V59, P160, DOI 10.1002/(SICI)1096-9071(199910)59:2<160::AID-JMV6>3.0.CO;2-Y
  32. DiBisceglie AM, 1996, ANN INTERN MED, V125, P772
  33. Ding X, 1999, VIRUS GENES, V19, P51, DOI 10.1023/A:1008188623062
  34. Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
  35. El-Zayadi AR, 1999, J VIROL METHODS, V80, P53, DOI 10.1016/S0166-0934(99)00036-1
  36. Feucht HH, 1997, J CLIN MICROBIOL, V35, P767
  37. Feucht HH, 1996, LANCET, V347, P615
  38. Giret MTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018407
  39. Hanci SY, 2008, MIKROBIYOL BUL, V42, P617
  40. Katayama K, 1998, ARCH VIROL, V143, P1063, DOI 10.1007/s007050050356
  41. KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0
  42. Lampe E, 1998, CLIN DIAGN VIROL, V9, P1, DOI 10.1016/S0928-0197(97)10017-4
  43. Levi Jose Eduardo, 2003, Revista do Instituto de Medicina Tropical de Sao Paulo, V45, P75, DOI 10.1590/S0036-46652003000200004
  44. Ling BH, 1998, WORLD J GASTROENTERO, V4, P489
  45. Lyra AC, 2005, BRAZ J MED BIOL RES, V38, P767, DOI 10.1590/S0100-879X2005000500015
  46. Mora MVA, 2010, J MED VIROL, V82, P1889, DOI 10.1002/jmv.21908
  47. Muerhoff AS, 1997, J VIROL, V71, P6501
  48. Mukaide M, 1997, FEBS LETT, V407, P51, DOI 10.1016/S0014-5793(97)00136-1
  49. Naito H, 2001, J VIROL METHODS, V91, P3, DOI 10.1016/S0166-0934(00)00207-X
  50. Okamoto H, 1997, J GEN VIROL, V78, P737
  51. Oubina JR, 1999, VIRUS RES, V65, P121, DOI 10.1016/S0168-1702(99)00109-4
  52. Pinho JRR, 1999, J CLIN MICROBIOL, V37, P1634
  53. Ramezani A, 2008, INT J INFECT DIS, V12, P57, DOI 10.1016/j.ijid.2007.04.010
  54. Ramos R, 2004, MEM I OSWALDO CRUZ, V99, P639, DOI 10.1590/S0074-02762004000600019
  55. RIBEIRODOS S, 2002, EUR J CLIN MICROBIOL, V21, P438
  56. Tanaka Y, 1998, AM J TROP MED HYG, V59, P462
  57. Thomas DL, 1997, J INFECT DIS, V176, P586
  58. Wiwanitkit V., 2006, Journal of Pediatric Infectious Diseases, V1, P83
  59. ZANINOVIC V, 1994, AIDS RES HUM RETROV, V10, P97, DOI 10.1089/aid.1994.10.97
  60. Zhu WF, 2003, WORLD J GASTROENTERO, V9, P1739

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - FM/MGT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/01
Artigos e Materiais de Revistas Científicas - LIM/07